Quest Report: H1N1 Crowds Out Other Flu Viruses
More than 99% of specimens tested for influenza were positive for H1N1 over approximately the past 11 months, according to a report from Quest Diagnostics Inc
Read MorePosted by Clinical Lab Products | May 6, 2010 | Miscellaneous |
More than 99% of specimens tested for influenza were positive for H1N1 over approximately the past 11 months, according to a report from Quest Diagnostics Inc
Read MorePosted by Clinical Lab Products | May 4, 2010 | Cancer, Miscellaneous |
Increasing costs and a decreasing workforce compel automation to be directed toward helping labs in repetitive and precise work.
Read MorePosted by Clinical Lab Products | May 1, 2010 | Cancer, Miscellaneous |
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read MorePosted by Clinical Lab Products | Apr 14, 2010 | Miscellaneous |
The National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for a two-year study, which will focus on development of novel, recombinant-based diagnostic tests for the Ebola and Marburg viruses.
Read MorePosted by Clinical Lab Products | Apr 12, 2010 | Infectious Diseases, Sexually Transmitted Diseases |
The first clinical studies comparing the READ (Real Amplicon Detection) PCR technology against established real-time PCR tests for tuberculosis (TB) and sexually transmitted infections found READ technology comparable for detecting positive results and superior in detecting false negative results.
Read More